News Oct 12, 2021 Neurotherapeutics pioneer MindMaze secures USD 125 million MindMaze, a global pioneer in the digital neurotherapeutics market, raised USD 125 million from AlbaCore Capital Group. This brings the Vaud-base...
News Aug 18, 2021 Debiopharm launches IDEAL, a new hub for life sciences Biopharmaceutical company Debiopharm has launched the “IDEAL” initiative to strengthen the Western Switzerland region as a hub for life science i...
News Nov 03, 2021 Opening of the NeuroTec research facility in Bern After almost two years of development, the NeuroTec research facility was launched. NeuroTec explores the use of modern medical technology to imp...
News May 11, 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...
News Sep 27, 2021 New offering for digital health start-ups in the Basel Area Basel Area Business & Innovation is expanding the offering of its DayOne Accelerator – both in terms of content and the area it covers. As such, ...
News Jul 21, 2021 GeNeuro raises EUR 6 million for multiple sclerosis treatment GeNeuro, a Geneva-based biopharmaceutical company developing new treatments for neurodegenerative diseases, has raised EUR 6 million through a pr...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News Apr 26, 2021 Record year for Western Switzerland’s biotech industry Biotechnology companies based in Switzerland have experienced record investments in the pandemic year 2020. The western Switzerland region, home ...
Press Release Mar 08, 2022 Switzerland Global Enterprise and Switzerland Tourism attract innovative companies to Switzerland As a location for innovation, Switzerland is predestined for the development of new business models with future technologies. The settlement of i...
News May 11, 2021 Vaud-based ophthalmic treatments specialist Oculis raises $ 57 million A biopharmaceutical company focused on developing innovative ophthalmic treatments, Oculis has announced the closing of an oversubscribed $ 57 mi...
News Feb 22, 2022 Digital neurotherapeutics specialist MindMaze secures USD 105 million MindMaze has closed a USD 105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate t...
News Jun 09, 2021 Swiss Motion Technologies’ 3D printed silicone sleeves get FIT boost Thanks to its automated manufacturing solution for improving disabled people’s mobility, Vaud-based start-up Swiss Motion Technologies was awarde...
News Jun 02, 2021 Eye diseases detection specialist EarlySight secures CHF 2.3 million EPFL spin-off EarlySight has secured CHF 2.3 million for the development of a medical device that helps doctors detect and treat eye diseases at ...
News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
Success stories May 25, 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
Success stories Apr 21, 2021 Deloitte’s Future of Health Initiative: “We have all of the parts of the value chain here, from R&D to manufacturing to commercialization.“ Switzerland is an important hub for the life sciences industry. It is the second largest exporter of packaged medicines in the world and home to ...